Innovations in medical research lead to novel medical devices and pharmaceuticals that ultimately must be critically evaluated before they can be considered standard of care. ICHI GmbH, specializing in reimbursement issues, offers the following services to aid in facilitating this process:
- Health Technology Assessment (HTA)
- assistance defining what is required for successful product adoption
- evidence evaluation and identification of existing evidence gaps
- design and implementation of clinical studies
- commissioning research
- minimization of processes that demonstrate and validate clinical value
- Reimbursement Solutions Strategy
- development for successful reimbursement positioning
- economic modeling
- hearing organization
- mediation services
- securing reimbursement
- diagnosis-related groups (DRGs)